Table 4. The correlation between KLK7, KLK10 expression and clinicopathological characteristics.

Clinicopathologic characteristics	KLK7 (n = 28)					KLK10 (n = 29)
	N	High (%)	Low (%)	P		N	High (%)	Low (%)	P
Age (yrs)				1.000					1.000
<60	15	11 (73.3%)	4 (26.7%)			16	8 (50%)	8 (50%)
≥60	13	9 (69.2%)	4 (30.8%)			13	7 (53.8%)	6 (46.2%)
Sex				0.083					0.060
Male	16	10 (62.5%)	6 (37.5%)			17	6 (35.3%)	11 (64.7%)
Female	12	11 (91.7%)	1 (8.3%)			12	9 (75%)	3 (25%)
Tumor size (cm)				0.462					0.700
<5	18	12 (66.7%)	6 (33.3%)			19	9 (47.4%)	10 (52.6%)
≥5	10	8 (80%)	2(20%)			10	6 (60%)	4 (40%)
Differentiation status				0.025*					0.466
Well + moderate	15	8 (53.3%)	7 (46.7%)			15	9 (60%)	6 (40%)
Poor	13	12 (92.3%)	1 (7.7%)			14	6 (42.9)	8 (57.1%)
Depth of invasion				0.007*					0.264
T1 + T2	15	8 (53.3%)	7 (46.7%)			17	7 (41.2%)	10 (58.8%)
T3 + T4	13	13(100%)	0 (0%)			12	8 (66.7%)	4 (33.3%)
Lymph node metastasis				0.401					1.000
Positive	12	10 (83.3%)	2 (16.7%)			13	7 (53.8%)	6 (46.2%)
Negative	16	10 (62.5%)	6 (37.5%)			16	8 (50%)	8 (50%)
TNM stage				0.086					0.651
I + II	22	14 (63.6%)	8 (36.4%)			23	11 (47.8%)	12 (52.2%)
III + IV	6	6 (100%)	0 (0%)			6	4 (66.7%)	2 (33.3%)

Notes.

^*P < 0.05.